Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luana Fianchi

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Haematology|January 23, 2013
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemiaMaria Teresa Voso, Massimo Breccia, Monia Lunghi, et al.
Leukemia Research|May 22, 2007
MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patientsPatrizia Chiusolo, Giovanni Reddiconto, Giuliana Farina, et al.
Haematologica|May 16, 2002
Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodesLivio Pagano, Luca Mele, Luana Fianchi, et al.
Haematologica|July 20, 2004
Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infectionLivio Pagano, Luana Fianchi, Cecilia Caramatti, et al.
Cytometry. Part B, Clinical Cytometry|December 9, 2017
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemiaFrancesco Corrente, Silvia Bellesi, Elisabetta Metafuni, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2011
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescuePatrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi, et al.
Oncotarget|January 12, 2017
Clonal evolution in therapy-related neoplasmsEmiliano Fabiani, Giulia Falconi, Luana Fianchi, et al.
Blood Cells, Molecules & Diseases|July 27, 2010
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasmsMariangela Greco, Francesco D'Alò, Alessandra Scardocci, et al.
Blood|January 16, 2024
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasisGiorgia Renga, Emilia Nunzi, Claudia Stincardini, et al.
Leukemia Research|August 7, 2019
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndromeGiulia Falconi, Emiliano Fabiani, Marianna Criscuolo, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Haematology|January 23, 2013
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemiaMaria Teresa Voso, Massimo Breccia, Monia Lunghi, et al.
Leukemia Research|May 22, 2007
MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patientsPatrizia Chiusolo, Giovanni Reddiconto, Giuliana Farina, et al.
Haematologica|May 16, 2002
Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodesLivio Pagano, Luca Mele, Luana Fianchi, et al.
Haematologica|July 20, 2004
Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infectionLivio Pagano, Luana Fianchi, Cecilia Caramatti, et al.
Cytometry. Part B, Clinical Cytometry|December 9, 2017
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemiaFrancesco Corrente, Silvia Bellesi, Elisabetta Metafuni, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2011
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescuePatrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi, et al.
Oncotarget|January 12, 2017
Clonal evolution in therapy-related neoplasmsEmiliano Fabiani, Giulia Falconi, Luana Fianchi, et al.
Blood Cells, Molecules & Diseases|July 27, 2010
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasmsMariangela Greco, Francesco D'Alò, Alessandra Scardocci, et al.
Blood|January 16, 2024
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasisGiorgia Renga, Emilia Nunzi, Claudia Stincardini, et al.
Leukemia Research|August 7, 2019
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndromeGiulia Falconi, Emiliano Fabiani, Marianna Criscuolo, et al.
Pageof 10